Market Overview:
The global bioburden testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing demand for bioburden testing products from the pharmaceutical and biotechnology industries, and the growing awareness about food safety among consumers. In terms of type, the global bioburden testing market is segmented into instruments and consumables. The instruments segment is expected to grow at a higher CAGR than the consumables segment during the forecast period. This can be attributed to the increasing demand for automated instruments in laboratories for faster and more accurate results. In terms of application, the global bioburden testing market is divided into pharmaceuticals, biotechnology, food & beverage industry, cosmetics industry, and others (agriculture & aquaculture).
Product Definition:
Bioburden testing is a laboratory procedure that quantifies the number of microorganisms present on or in a sample. The purpose of bioburden testing is to assess the potential for contamination and infection.
Instruments:
Instruments are used for testing the bioburden in water, food & beverage and pharmaceutical industries. It is a tool that helps to measure or detect microorganisms such as bacteria, viruses or other single-cell organisms. The growth factor in instruments market includes factors such as increasing demand from various end-use industries along with technological advancements by instrument manufacturers.
Consumables:
Consumables are the instruments or devices that are used in bioburden testing. It can be further categorized as reagents, kits, and assay formats. Bioburden testing is a process of determining the concentration of microorganisms such as bacteria and viruses in an environment using consumables by performing some specific tests.
Application Insights:
The pharmaceutical application segment dominated the global bioburden testing market in 2017. This is attributed to the rising prevalence of chronic diseases, such as cancer and diabetes, which require a high number of drug candidates for clinical trials. The presence of stringent regulations pertaining to biohazards in pharmaceutical industries across various regions is also driving the growth of this segment.
The increasing need for advanced therapeutics that can cure or at least alleviate the sufferings caused by these chronic diseases has led researchers from around the world to focus on finding new ways and means for developing drugs with better outcomes. As a result, there has been an increase in R&D activities pertaining to novel drug development over recent years. This trend is expected continue over next few years thereby fueling product demand during forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of biotechnology and pharmaceutical companies, which are majorly involved in drug discovery and development processes. The U.S.-based companies have been observed to be focusing on novel technologies that would help them develop better assays for their research work, thus driving regional growth over the forecast period.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to increasing R&D activities by various pharmaceutical and biotech firms operating within this region coupled with rising healthcare spending by governments across emerging economies such as China, India, Singapore, Thailand among others will drive regional demand for bioburden testing instruments & consumables over next eight years - 2030 - The key countries considered while analyzing Asia Pacific’s market share are Japan (35%), China (30%) South Korea (5%) among other Asian countries including Indonesia & Malaysia etc.
Growth Factors:
- Increasing demand for bioburden testing in the food and beverage industry as a result of growing consumer awareness about food safety.
- Rising incidence of foodborne illnesses, which is driving the demand for bioburden testing services.
- Growing number of outbreaks caused by pathogenic microorganisms, which is fueling the demand for bioburden testing services worldwide.
- Proliferation of new pathogens that are difficult to detect and control, which is leading to an increase in the demand for bioburden testing services globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
Bioburden Testing Market Research Report
By Type
Instruments, Consumables
By Application
Pharmaceutical, Biotechnology
By Companies
Charles River Laboratories International, Sigma-Aldrich, SGS, Wuxi Pharmatech (CAYMAN), Merck, Becton Dickinson, North American Science Associates Inc., Nelson Laboratories, Pacific Biolabs, ATS Labs
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
131
Number of Tables & Figures
92
Customization Available
Yes, the report can be customized as per your need.
Global Bioburden Testing Market Report Segments:
The global Bioburden Testing market is segmented on the basis of:
Types
Instruments, Consumables
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical, Biotechnology
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Charles River Laboratories International
- Sigma-Aldrich
- SGS
- Wuxi Pharmatech (CAYMAN)
- Merck
- Becton Dickinson
- North American Science Associates Inc.
- Nelson Laboratories
- Pacific Biolabs
- ATS Labs
Highlights of The Bioburden Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Instruments
- Consumables
- By Application:
- Pharmaceutical
- Biotechnology
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bioburden Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bioburden testing is a laboratory technique used to determine the toxicity of microorganisms and other biological materials. The test organism is exposed to a controlled environment that mimics the conditions found in the human body. This allows researchers to study how these organisms interact with each other and their host cells.
Some of the major players in the bioburden testing market are Charles River Laboratories International, Sigma-Aldrich, SGS, Wuxi Pharmatech (CAYMAN), Merck, Becton Dickinson, North American Science Associates Inc., Nelson Laboratories, Pacific Biolabs, ATS Labs.
The bioburden testing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bioburden Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bioburden Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bioburden Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bioburden Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bioburden Testing Market Size & Forecast, 2020-2028
4.5.1 Bioburden Testing Market Size and Y-o-Y Growth
4.5.2 Bioburden Testing Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Instruments
5.2.2 Consumables
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pharmaceutical
6.2.2 Biotechnology
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bioburden Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bioburden Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Instruments
9.6.2 Consumables
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pharmaceutical
9.10.2 Biotechnology
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Instruments
10.6.2 Consumables
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pharmaceutical
10.10.2 Biotechnology
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Instruments
11.6.2 Consumables
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pharmaceutical
11.10.2 Biotechnology
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Instruments
12.6.2 Consumables
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pharmaceutical
12.10.2 Biotechnology
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Instruments
13.6.2 Consumables
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pharmaceutical
13.10.2 Biotechnology
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bioburden Testing Market: Competitive Dashboard
14.2 Global Bioburden Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Charles River Laboratories International
14.3.2 Sigma-Aldrich
14.3.3 SGS
14.3.4 Wuxi Pharmatech (CAYMAN)
14.3.5 Merck
14.3.6 Becton Dickinson
14.3.7 North American Science Associates Inc.
14.3.8 Nelson Laboratories
14.3.9 Pacific Biolabs
14.3.10 ATS Labs
